Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

JNJ 10198409

Known as: JNJ-10198409, JNJ10198409 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Glioblastomas are highly resistant to radiation and chemotherapy. Currently, there are no effective therapies for this type of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2017
2017
Increased expression of PDGF receptor-β (PDGFRβ) has been shown in renal proximal tubules in mice with diabetes. The core… Expand
2014
2014
Mesenchymal stem cells (MSCs) play an important role in matrix remodeling, fibroblast activation, angiogenesis, and… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2014
2014
We showed previously that proliferating human islet‐derived de‐differentiated cells (DIDs) exhibit many characteristics of… Expand
2013
2013
Glioblastoma multiforme (GBM) is the most common primary brain cancer in adults and there are few effective treatments. GBMs… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2012
2012
Extensive first-pass metabolism can significantly limit a drug's oral exposure levels. In this work, we introduce an innovative… Expand
2006
2006
The potential cancer therapeutic agent, 6,7-(dimethoxy-2, 4-dihydroindeno[1,2-c]pyrazol-3-yl)-(3-fluoro-phenyl)-amine (JNJ… Expand
  • figure 1
  • table 1
  • table 2
  • figure 3
  • figure 2
2006
2006
The potential cancer therapeutic agent, 6,7-(dimethoxy-2,4-dihydroindeno[1,2c]pyrazol-3-yl)-(3-fluoro-phenyl)-amine (JNJ-10198409… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
2005
2005
A series of (6,7-dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines has been optimized to preserve both potent kinase… Expand
2005
2005
With the advent of agents directed against specific molecular targets in drug discovery, it has become imperative to show a… Expand
  • figure 2
  • figure 1
  • figure 4
  • figure 3
  • figure 5